Posted On: 01/05/2015 11:15:07 AM
Post# of 7769
Alleyba says..............................
..............that it is very unusual for a company like Zacks to profile and initiate coverage on a penny stock. Alleyba says, in his opinion, that this bodes very well for SCRC. Alleyba thinks this demonstrates to a certain degree that SCRC is starting to hit the radar and he would not be surprised if it starts attracting the attention of brokers in some of the large firms. Zacks placed earnings at .04. Alleyba believes this was a lower conservative number than it will actually be for this year.............but let us say for a minute .04 is the right number. Would it be out of the question to take a multiple of 10-15X earnings and say this is easily a .40-.60 cent stock based on their numbers?
Alleyba also believes the .04 does not take into consideration RX, PIMD and Rapi Meds which Alleyba believes will one day occur and once all the parts are moving at the same time this stock easily runs to a $1. Does anyone disagree?
..............that it is very unusual for a company like Zacks to profile and initiate coverage on a penny stock. Alleyba says, in his opinion, that this bodes very well for SCRC. Alleyba thinks this demonstrates to a certain degree that SCRC is starting to hit the radar and he would not be surprised if it starts attracting the attention of brokers in some of the large firms. Zacks placed earnings at .04. Alleyba believes this was a lower conservative number than it will actually be for this year.............but let us say for a minute .04 is the right number. Would it be out of the question to take a multiple of 10-15X earnings and say this is easily a .40-.60 cent stock based on their numbers?
Alleyba also believes the .04 does not take into consideration RX, PIMD and Rapi Meds which Alleyba believes will one day occur and once all the parts are moving at the same time this stock easily runs to a $1. Does anyone disagree?
(0)
(0)
